B****A
发帖数: 816 | 1 Independent Data Monitoring Committee Recommends Continuation of Spectrum
Pharmaceuticals’ Pivotal Registrational Study of Belinostat in Peripheral T
-Cell Lymphoma
•Independent Data Monitoring Committee (DMC) Recommends That the
BELIEF Study Continue According to Protocol Until 100 Evaluable Patients
Enrolled
•No Safety Concerns Raised Based on DMC Safety Analysis
http://www.businesswire.com/news/home/20110328005575/en/Indepen |
|
y*****l
发帖数: 5997 | 2 来自主题: _pennystock版 - SPPI Spectrum Pharmaceuticals Announces ZEVALIN(R) and Belinostat Abstracts to Be
Presented at the American Society of Clinical Oncology Annual Meeting
4 hours 16 minutes ago - BIZ via Comtex
BusinessWireSpectrum Pharmaceuticals (NasdaqGS: SPPI), a biotechnology
company with fully integrated commercial and drug development operations
with a primary focus in oncology, today announced ZEVALIN(R) (ibritumomab
tiuxetan) and Belinostat abstracts will be presented at the 2011 Annual
Meeting of the American... 阅读全帖 |
|
y*****l
发帖数: 5997 | 3 下周可能有戏 December 4-7
Spectrum Pharmaceuticals Announces Presentation of Four Key Belinostat
Abstracts at the 52nd Annual Meeting of the American Society of Hematology (
ASH) in Orlando, Florida on December 4-7, 2010
Thursday 11/18/2010 7:00 AM ET - Businesswire
Related Companies
Symbol Last %Chg
SPPI 4.45 -2.84%
As of 4:00 PM ET 11/30/10
Spectrum Pharmaceuticals, Inc. (NasdaqGM: SPPI), a biotechnology company
with fully integrated commercial and drug development operations with a
... 阅读全帖 |
|
y*****l
发帖数: 5997 | 4 Pre market up.
Spectrum Pharmaceuticals Announces Record Revenue and Record Profit in First
Quarter 2011
28 minutes ago - BIZ via Comtex
BusinessWire--Anticipate Reporting a Record Quarterly Profit in the First
Quarter 2011 Second Consecutive Profitable Quarter
--FUSILEV(R) sNDA For Use In Advanced Metastatic Colorectal Cancer is
Currently Under Review by the FDA PDUFA Action Date -- This Week -- April 29
, 2011
--ZEVALIN(R) Prior Approval Supplement for the Removal of the Bioscan
Requirement Cu... 阅读全帖 |
|
y*****l
发帖数: 5997 | 5 11:55 Do you think there is > 50% chance someone buys HGSI in next 12 mos.?
Yes
( 68% )No
( 32% )
Thursday October 20, 2011 11:55
11:56 adam feuerstein: Hello! Welcome to the October edition of Biotech
Stock Live Chat.
Thursday October 20, 2011 11:56 adam feuerstein
12:02 adam feuerstein: hi everyone
Thursday October 20, 2011 12:02 adam feuerstein
12:02 adam feuerstein: I'll get started in a minute or so, let folks log in
.
Thursday October 20, 2011 12:02 adam feuerstein
12:02 adam feuers... 阅读全帖 |
|
g****e
发帖数: 1426 | 6 Just want to share some thoughts on recent biotech stocks bought or
currently holding:
AMRN: since all in, sold all @ mid 14. Re-enter below 13 and added more this
Friday. Performance +. Looking for buyout and recongnition of the
blockbuster market potential of its drug vascepa.
CPRX: sold in mid 1.3 with loss. Performance -. Dilution and its
questionable ownership of the drug keep me away from re-entering.
DVAX: sold. Good stock to own now. Still has room to run, but maybe pull
back some time ... 阅读全帖 |
|
g****e
发帖数: 1426 | 7 I don't have them anymore. Hznp will have eu approval too this month.
Sppi belinostat data will be this month. Amrn NCE/Bo ... So many exciting,
going to be a very volatility period for these biotech stocks. Trading them
accordingly. Good luck!! |
|
y*****l
发帖数: 5997 | 8 来自主题: _pennystock版 - sppi SPPI总算开始动了，今天逆势上涨应该是由于这条消息：
Spectrum Pharma Backs Fusilev, Belinostat, Apaziquone FDA Filings In 2010,
2011, 2012, Respectively
Monday 08/09/2010 4:19 PM ET - Dow Jones News
Trading Higher on Heavy Volume are Shares of Spectrum Pharmaceuticals on 1.
1x Above-Average Volume (SPPI)
Tuesday 08/10/2010 1:58 PM ET - Comtex Smartrend(r)
Related Companies
Symbol Last %Chg
SPPI 4.50 6.64%
As of 4:00 PM ET 8/10/10
Shares of Spectrum Pharmaceuticals (NASDAQ:SPPI) are trading up 4% to $4.39... 阅读全帖 |
|
f**********g
发帖数: 2252 | 9 Conf tommorow. December 4-7
发信人: yaokarl (大象), 信区: pennystock
标 题: Re: 推荐sppi
发信站: BBS 未名空间站 (Tue Nov 30 21:51:22 2010, 美东)
下周可能有戏 December 4-7
Spectrum Pharmaceuticals Announces Presentation of Four Key Belinostat
Abstracts at the 52nd Annual Meeting of the American Society of Hematology (
ASH) in Orlando, Florida on December 4-7, 2010 |
|
|
v**********m
发帖数: 5516 | 11 来自主题: _pennystock版 - sppi http://www.businesswire.com/news/home/20110421006626/en/Spectru
April 21, 2011 02:42 PM Eastern Daylight Time
Spectrum Pharmaceuticals Announces FDA Approval of FUSILEV®’s Ready-to
-Use Formulation (RTU)
* Until Now FUSILEV® Has Been Available Only As A Lyophilized
Product
* FUSILEV® sNDA For Use In Advanced Metastatic Colorectal Cancer is
Currently Under Review By The FDA
o PDUFA Action Date – April 29, 2011
* FUSILEV® Is Currently FDA Approved and Mark... 阅读全帖 |
|
